021-51111890
购物车（）
sales@molnova.cn
首页-
Products -
Others -
Other Targets -
2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid hydrochloride
2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid hydrochloride
CAS No. 128090-87-9
2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid hydrochloride ( —— )
产品货号. M28411 CAS No. 128090-87-9
2-(2-氨基-3-甲基丁酰胺基)-3-苯基丙酸盐酸盐是一种化合物。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥398 | 有现货 |
|
| 10MG | ￥594 | 有现货 |
|
| 25MG | ￥995 | 有现货 |
|
| 50MG | ￥1488 | 有现货 |
|
| 100MG | ￥2061 | 有现货 |
|
| 200MG | ￥2889 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ￥358 | 有现货 |
|
生物学信息
-
产品名称2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid hydrochloride
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述2-(2-氨基-3-甲基丁酰胺基)-3-苯基丙酸盐酸盐是一种化合物。
-
产品描述2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid hydrochloride is a chemical compound.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Unusual Amino Acids
-
研究领域——
-
适应症——
化学信息
-
CAS Number128090-87-9
-
分子量300.781
-
分子式C14H21ClN2O3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCl.CC(C)C(N)C(=O)NC(Cc1ccccc1)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Leung K. 8-[(123)I]Iodo-L-1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid. 2007 Feb 22 [updated 2008 May 12]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK23698/ PubMed PMID: 20641893.
产品手册
关联产品
-
Microtubule-associat...
Microtubule-associated protein tau (26-44) is a synthetic peptide chain with an amine group attached to glutamine and an carboxyl group attached to lysine.
-
Copper(II) D-glucona...
D-葡萄糖酸铜(II)粉末与硅结合用于制造碳包覆的Si-Cu3Si复合材料作为锂离子电池的负极材料。
-
7-(4-Hydroxyphenyl)-...
7-(4-Hydroxyphenyl)-1-phenyl-4-hepten-3-one as a beneficial compound to ameliorate the deleterious effects of Aβ on dendrite integrity and cell survival, and may provide new insights on drug discovery of Alzheimer's disease (AD).
